Total Payments
$4,679
2024 Payments
$797.01
Companies
31
Transactions
277
Medicare Patients
3,327
Medicare Billing
$739,797
Payment Breakdown by Category
Food & Beverage$4,512 (96.4%)
Education$166.78 (3.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,512 | 259 | 96.4% |
| Education | $166.78 | 18 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $568.58 | 31 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $513.35 | 32 | $0 (2024) |
| Horizon Therapeutics plc | $407.49 | 31 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $387.09 | 17 | $0 (2019) |
| Vifor Pharma, Inc. | $377.63 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $306.90 | 18 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $276.15 | 15 | $0 (2024) |
| Relypsa, Inc. | $261.21 | 15 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $236.40 | 12 | $0 (2024) |
| Daiichi Sankyo Inc. | $188.68 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $797.01 | 41 | Amgen Inc. ($193.59) |
| 2023 | $611.78 | 34 | Fresenius USA Marketing, Inc. ($145.67) |
| 2022 | $841.92 | 42 | Otsuka America Pharmaceutical, Inc. ($149.16) |
| 2021 | $778.61 | 57 | Horizon Therapeutics plc ($193.94) |
| 2020 | $249.84 | 19 | Mallinckrodt Hospital Products Inc. ($72.83) |
| 2019 | $463.40 | 29 | Amgen Inc. ($83.44) |
| 2018 | $345.89 | 23 | Mallinckrodt LLC ($158.91) |
| 2017 | $590.81 | 32 | Mallinckrodt LLC ($204.53) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.71 | General |
| 12/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Nephrology | ||||||
| 10/28/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Cardio-renal | ||||||
| 09/09/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Inflammation | ||||||
| 08/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Inflammation | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Inflammation | ||||||
| 07/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Inflammation | ||||||
| 06/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: NEPHROLOGY | ||||||
| 05/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.31 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 739 | 1,634 | $501,059 | $152,097 |
| 2022 | 10 | 767 | 1,740 | $541,710 | $161,626 |
| 2021 | 10 | 863 | 1,998 | $674,329 | $218,558 |
| 2020 | 15 | 958 | 2,189 | $717,400 | $207,516 |
Total Patients
3,327
Total Services
7,561
Medicare Billing
$739,797
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 528 | $145,570 | $37,377 | 25.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 155 | 416 | $110,448 | $36,844 | 33.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 24 | 95 | $68,486 | $24,797 | 36.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 130 | 346 | $64,148 | $20,721 | 32.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 94 | 95 | $49,077 | $12,499 | 25.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 20 | 53 | $32,150 | $11,438 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $12,097 | $3,426 | 28.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 36 | $12,539 | $3,407 | 27.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 24 | $4,320 | $934.20 | 21.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 11 | 12 | $2,225 | $653.16 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 225 | 517 | $142,537 | $36,930 | 25.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 21 | 137 | $98,763 | $36,617 | 37.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 157 | 465 | $123,458 | $36,072 | 29.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 146 | 377 | $69,896 | $20,419 | 29.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 94 | 96 | $49,594 | $14,073 | 28.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 14 | 28 | $16,985 | $6,160 | 36.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 43 | $14,977 | $4,385 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 27 | $9,974 | $2,948 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $11,263 | $2,747 | 24.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 20 | 23 | $4,264 | $1,275 | 29.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 46 | 231 | $166,528 | $61,523 | 36.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 263 | 575 | $158,528 | $49,528 | 31.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 183 | 524 | $139,122 | $40,840 | 29.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 136 | 388 | $71,935 | $21,162 | 29.4% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 38 | 73 | $44,282 | $16,869 | 38.1% |
About Dr. Ernest Han, MD
Dr. Ernest Han, MD is a Nephrology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942357744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ernest Han, MD has received a total of $4,679 in payments from pharmaceutical and medical device companies, with $797.01 received in 2024. These payments were reported across 277 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,512).
As a Medicare-enrolled provider, Han has provided services to 3,327 Medicare beneficiaries, totaling 7,561 services with total Medicare billing of $739,797. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Gainesville, GA
- Active Since 01/04/2007
- Last Updated 01/16/2019
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1942357744
Products in Payments
- Veltassa (Drug) $617.63
- ACTHAR (Biological) $539.04
- KRYSTEXXA (Biological) $453.64
- Velphoro (Drug) $413.86
- Kerendia (Drug) $236.40
- FARXIGA (Drug) $214.18
- JYNARQUE (Drug) $211.58
- INJECTAFER (Drug) $188.68
- LUPKYNIS (Drug) $168.41
- TAVNEOS (Drug) $147.44
- Parsabiv (Biological) $135.88
- Parsabiv (Drug) $96.19
- Auryxia (Drug) $85.27
- Tavneos (Drug) $84.23
- AURYXIA (Drug) $82.88
- LOKELMA (Drug) $79.53
- Rayaldee (Drug) $73.94
- SAMSCA (Drug) $64.57
- Sensipar (Drug) $58.69
- TARPEYO (Drug) $53.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Gainesville
Dr. Abdul Khan, Md, MD
Nephrology — Payments: $14,369
Nephrology $14,369
Dr. Dimpu Patel, M.d, M.D
Nephrology — Payments: $6,090
Nephrology $6,090
Sohail Ejaz, Md, MD
Nephrology — Payments: $5,233
Nephrology $5,233
Deepak Aggarwal, M.d, M.D
Nephrology — Payments: $5,162
Nephrology $5,162
Dr. I Weiner, Md, MD
Nephrology — Payments: $4,521
Nephrology $4,521
Sohail Saleem, M.d, M.D
Nephrology — Payments: $4,426
Nephrology $4,426